GE Healthcare launched this week its Amersham Hyperfilm Blue film for the detection of chemiluminescent signals in various blotting assays.
According to the company, the new film offers lower sensitivity than Amersham Hyperfilm, enabling researchers to produce faster qualitative results in Western, Southern, and Northern blots, reducing minimal exposure time to as little as one minute.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
